Tue, January 16, 2018
Fri, January 12, 2018
Thu, January 11, 2018
Wed, January 10, 2018
Tue, January 9, 2018
Mon, January 8, 2018
Fri, January 5, 2018
Thu, January 4, 2018
Wed, January 3, 2018
Tue, January 2, 2018
Tue, December 26, 2017
Fri, December 22, 2017
Thu, December 21, 2017
Wed, December 20, 2017
Tue, December 19, 2017
Mon, December 18, 2017
Fri, December 15, 2017
Thu, December 14, 2017
Wed, December 13, 2017
Tue, December 12, 2017
Mon, December 11, 2017
Fri, December 8, 2017
Thu, December 7, 2017
Wed, December 6, 2017
Tue, December 5, 2017

Andrew Schenker Downgraded (THC) to Sell on, Dec 20th, 2017


//stocks-investing.news-articles.net/content/201 .. ker-downgraded-thc-to-sell-on-dec-20th-2017.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Andrew Schenker of Morgan Stanley, Downgraded "Tenet Healthcare Corporation" (THC) to Sell on, Dec 20th, 2017.

Andrew has made no other calls on THC in the last 4 months.



There are 5 other peers that have a rating on THC. Out of the 5 peers that are also analyzing THC, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Scott Fidel of "Credit Suisse" Initiated at Hold and Held Target at $15 on, Thursday, November 2nd, 2017


These are the ratings of the 4 analyists that currently disagree with Andrew


  • Gary Taylor of "JP Morgan" Downgraded from Hold to Sell on, Thursday, December 14th, 2017
  • Ralph Giacobbe of "Citigroup" Upgraded from Hold to Strong Buy on, Tuesday, December 12th, 2017
  • Brian Tanquilut of "Jefferies" Maintained at Strong Buy with Decreased Target to $20 on, Monday, October 30th, 2017
  • Ana Gupte of "Leerink Swann" Maintained at Buy with Increased Target to $30 on, Monday, August 21st, 2017

Publication Contributing Sources